This announcement is a separate document:
华润三九医药股份有限公司拟向昆药集团股份有限公司转让昆明华润圣火药业有限公司51%股权项目资产评估报告
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. intends to transfer a 51% stake in Kunming China Resources Shenghuo Pharmaceutical Co., Ltd. to KPC Pharmaceuticals, Inc. Asset evaluation report of the project.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.